Ahrén, Bo. 2013. “Incretin Therapy for Type 2 Diabetes: GLP-1 Receptor Agonists and DPP-4 Inhibitors”. International Diabetes Nursing 10 (1):31-36. https://doi.org/10.1002/edn.221.